Evidence map›Paper›PMID 35116872›Full record

ArticleTranslational cancer research2019

Role of PI3K/Akt pathway in Benzidine-induced proliferation in SV-40 immortalized human uroepithelial cell.

Demao Ding, Zhiqi Liu, Li Zhao, Hao Geng, Zhaofeng Liang, Dexin Yu

Open access · diamondAbstract read
In one paragraph

Article in Translational cancer research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.7field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Demao Ding *Department of Urologic Surgery, the Second Affiliated Hospital of Anhui Medical University, Hefei 230032, China.
Zhiqi Liu *Department of Urologic Surgery, the Second Affiliated Hospital of Anhui Medical University, Hefei 230032, China.
Li ZhaoDepartment of Urologic Surgery, Nanjing Jiangbei People's Hospital, Nanjing 210048, China.
Hao GengDepartment of Urologic Surgery, the Second Affiliated Hospital of Anhui Medical University, Hefei 230032, China.
Zhaofeng LiangDepartment of Nutrition and Food Safety, School of Public Health, Nanjing Medical University, Nanjing 211166, China.
Dexin YuDepartment of Urologic Surgery, the Second Affiliated Hospital of Anhui Medical University, Hefei 230032, China.
Anhui Medical University · CNSecond Hospital of Anhui Medical University · CNNanjing Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundLong term exposure to benzidine has been determined as a cause of urothelial carcinoma. But how it works in the process of cell proliferation that involves in tumor growth is not examined yet. In the current research, the effect of PI3K/Akt on cell proliferation mediated by benzidine was confirmed.

methodsThe immortalized SV-40 human uroepithelial cells (SV-HUC-1) had been subjected to 6 days of benzidine treatment at various contents, then MTT assay, together with subsequent flow cytometry assay were used for observing effects on cell proliferation. Further Western blots were used to detect the expression of total-Akt, phospho-Akt and specific proteins of cell cycle. The Akt, Cyclin D1, PCNA and P21 mRNA levels were detected through RT-PCR. In addition, the blocker-LY294002 was used to cut down the PI3K/Akt signaling pathway. And then those parameters were detected using the same methods as above.

resultsResults showed that benzidine acted to induce cell proliferation at low doses (P<0.05

conclusionsActivated PI3K/Akt signal pathway promotes benzidine-triggered cell proliferation. It may shed light on the molecular mechanisms that the activated PI3K/Akt pathway promotes benzidine-triggered cell proliferation and intervention of its target.

Indexed as

Benzidinecell proliferationPI3K/AktSV-40 human uroepithelial cells (SV-HUC-1)

Identifiers

PMID35116872
PMCPMC8798037
OpenAlexW4243934964

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.